Literature DB >> 16893986

Mycobacterium tuberculosis HBHA protein reacts strongly with the serum immunoglobulin M of tuberculosis patients.

A-Rum Shin1, Kil-Soo Lee, Ji-Sook Lee, Su-Young Kim, Chang-Hwa Song, Saet-Byel Jung, Chul-Su Yang, Eun-Kyeong Jo, Jeong-Kyu Park, Tae-Hyun Paik, Hwa-Jung Kim.   

Abstract

Identification and characterization of serologically active mycobacterial antigens are prerequisites for the development of diagnostic reagents. We examined the humoral immune responses of active tuberculosis (TB) patients against Triton-soluble proteins extracted from Mycobacterium tuberculosis by immunoblotting. A 29-kDa protein reacted with immunoglobulin M (IgM) in the pooled sera of the patients, and its N-terminal amino acid sequence matched that of the heparin-binding hemagglutinin (HBHA). Recombinant full-length HBHA was expressed in Escherichia coli (rEC-HBHA) and M. smegmatis (rMS-HBHA). In immunoblot analysis, the IgM antibodies of the TB patients reacted strongly with rMS-HBHA but not with rEC-HBHA, whereas the IgG antibodies of these patients reacted weakly with both recombinant HBHA proteins. In enzyme-linked immunosorbent assay analysis using rMS-HBHA and 85B as antigens, the mean levels and sensitivities of the anti-HBHA IgM antibodies of the TB patients were significantly higher than those of the anti-antigen 85B IgM antibodies, while the IgG antibodies showed the opposite results. Of interest in this respect, the pooled sera from the TB patients that contained anti-HBHA IgM antibodies neutralized the entry of M. tuberculosis into epithelial cells. These findings suggest that IgM antibody to HBHA may play a role in protection against extrapulmonary dissemination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893986      PMCID: PMC1539112          DOI: 10.1128/CVI.00103-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  25 in total

1.  Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis.

Authors:  Chantal Masungi; Stéphane Temmerman; Jean-Paul Van Vooren; Annie Drowart; Kevin Pethe; Franco D Menozzi; Camille Locht; Françoise Mascart
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

Review 2.  Immunologic diagnosis of tuberculosis: a review.

Authors:  E D Chan; L Heifets; M D Iseman
Journal:  Tuber Lung Dis       Date:  2000

Review 3.  Immunologic diagnosis of tuberculosis.

Authors:  M L Gennaro
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

4.  Interaction of Mycobacterium tuberculosis with human respiratory epithelial cells (HEp-2).

Authors:  V M Reddy; D A Hayworth
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

5.  Mycobacterial protein HbhA binds human complement component C3.

Authors:  S L Mueller-Ortiz; A R Wanger; S J Norris
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis.

Authors:  Alamelu Raja; K R Uma Devi; B Ramalingam; Patrick J Brennan
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

7.  Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis.

Authors:  Kevin Pethe; Pablo Bifani; Hervé Drobecq; Christian Sergheraert; Anne-Sophie Debrie; Camille Locht; Franco D Menozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis.

Authors:  Giovanni Delogu; Alessandra Bua; Cinzia Pusceddu; Marcela Parra; Giovanni Fadda; Michael J Brennan; Stefania Zanetti
Journal:  FEMS Microbiol Lett       Date:  2004-10-01       Impact factor: 2.742

9.  Use of multiepitope polyproteins in serodiagnosis of active tuberculosis.

Authors:  Raymond L Houghton; Michael J Lodes; Davin C Dillon; Lisa D Reynolds; Craig H Day; Patricia D McNeill; Ronald C Hendrickson; Yasir A W Skeiky; Diana P Sampaio; Roberto Badaro; Konstantin P Lyashchenko; Steven G Reed
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

10.  Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin.

Authors:  Stéphane Temmerman; Kevin Pethe; Marcela Parra; Sylvie Alonso; Carine Rouanet; Thames Pickett; Annie Drowart; Anne-Sophie Debrie; Giovanni Delogu; Franco D Menozzi; Christian Sergheraert; Michael J Brennan; Françoise Mascart; Camille Locht
Journal:  Nat Med       Date:  2004-08-08       Impact factor: 53.440

View more
  17 in total

1.  Highly immunoreactive antibodies against the rHup-F2 fragment (aa 63-161) of the iron-regulated HupB protein of Mycobacterium tuberculosis and its potential for the serodiagnosis of extrapulmonary and recurrent tuberculosis.

Authors:  N Sritharan; M Choudhury; S Sivakolundu; R Chaurasia; N Chouhan; P P Rao; M Sritharan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-19       Impact factor: 3.267

2.  Serodiagnostic potential of Mycobacterium avium MAV2054 and MAV5183 proteins.

Authors:  A-Rum Shin; Kil-Soo Lee; Kang In Lee; Tae Sun Shim; Won-Jung Koh; Haet Sal Jeon; Yeo-Jin Son; Sung-Jae Shin; Hwa-Jung Kim
Journal:  Clin Vaccine Immunol       Date:  2012-12-26

3.  Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.

Authors:  Giovanni Delogu; Teresa Chiacchio; Valentina Vanini; Ornella Butera; Gilda Cuzzi; Alessandra Bua; Paola Molicotti; Stefania Zanetti; Francesco Nicola Lauria; Susanna Grisetti; Nicola Magnavita; Giovanni Fadda; Enrico Girardi; Delia Goletti
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

4.  Detection of pathogenic mycobacteria based on functionalized quantum dots coupled with immunomagnetic separation.

Authors:  Emmanouil Liandris; Maria Gazouli; Margarita Andreadou; Leonardo A Sechi; Valentina Rosu; John Ikonomopoulos
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

5.  Mycobacterial heparin-binding haemagglutinin adhesion-induced interferon & antibody for detection of tuberculosis.

Authors:  Zhaogang Sun; Lihui Nie; Xuxia Zhang; Yan Li; Chuanyou Li
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

6.  Mycobacterial Heparin-binding Hemagglutinin Antigen Activates Inflammatory Responses through PI3-K/Akt, NF-κB, and MAPK Pathways.

Authors:  Ki-Hye Kim; Chul-Su Yang; A-Rum Shin; So-Ra Jeon; Jeong-Kyu Park; Hwa-Jung Kim; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2011-04-30       Impact factor: 6.303

7.  Targeting of Mycobacterium tuberculosis heparin-binding hemagglutinin to mitochondria in macrophages.

Authors:  Hosung Sohn; Jong-Seok Kim; Sung Jae Shin; Kwangwook Kim; Choul-Jae Won; Woo Sik Kim; Ki-Nam Min; Han-Gyu Choi; Je Chul Lee; Jeong-Kyu Park; Hwa-Jung Kim
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

8.  Association between haptoglobin and IgM levels and the clinical progression of caseous lymphadenitis in sheep.

Authors:  Bruno L Bastos; Dan Loureiro; José T Raynal; Maria T Guedes; Vera Lúcia Costa Vale; Lilia F Moura-Costa; José E Guimarães; Vasco Azevedo; Ricardo W Portela; Roberto Meyer
Journal:  BMC Vet Res       Date:  2013-12-13       Impact factor: 2.741

9.  Pilot study of diagnostic potential of the Mycobacterium tuberculosis recombinant HBHA protein in a vaccinated population in Finland.

Authors:  Laura Savolainen; Liana Pusa; Hwa-Jung Kim; Heidi Sillanpää; Ilkka Seppälä; Tamara Tuuminen
Journal:  PLoS One       Date:  2008-09-25       Impact factor: 3.240

10.  IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis.

Authors:  Xiaoyan Feng; Xiqin Yang; Bingshui Xiu; Shuang Qie; Zhenhua Dai; Kun Chen; Ping Zhao; Li Zhang; Russell A Nicholson; Guohua Wang; Xiaoguo Song; Heqiu Zhang
Journal:  BMC Infect Dis       Date:  2014-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.